You have 9 free searches left this month | for more free features.

ibrutinib

Showing 1 - 25 of 187

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Ibrutinib
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 13, 2022

Chronic Lymphocytic Leukemia, Loss of Chromosome 17p Trial (Ibrutinib, Venetoclax)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Loss of Chromosome 17p
  • (no location specified)
Oct 29, 2021

Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Ibrutinib
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 13, 2022

Relapsed/Refractory Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Leukemia Trial in Switzerland (Ibrutinib,

Active, not recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • +2 more
  • Aarau, Switzerland
  • +10 more
Mar 10, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • MYD88 Gene Mutation
  • Boston, Massachusetts
  • +1 more
Apr 1, 2022

Waldenstrom Macroglobulinemia Trial in Austria, Germany, Greece (Carfilzomib + Ibrutinib, Ibrutinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Carfilzomib + Ibrutinib
  • Ibrutinib
  • Salzburg, Austria
  • +16 more
Mar 11, 2022

Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

Recruiting
  • Ependymoma
  • +3 more
  • Ibrutinib
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
Mar 20, 2022

Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

Terminated
  • Small Lymphocytic Leukemia (SLL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 15, 2022

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Apr 2, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Graft Vs Host Disease Trial in Atlanta (Rituximab, Ibrutinib)

Recruiting
  • Graft Vs Host Disease
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

Prostate Cancer Trial in San Francisco, Saint Louis (Ibrutinib, Blood samples for PSA and immune assays, Radical prostatectomy)

Recruiting
  • Prostate Cancer
  • Ibrutinib
  • +2 more
  • San Francisco, California
  • +1 more
Aug 15, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 1, 2022

Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

Completed
  • Metastatic Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 8, 2022

Colon Cancer, Colorectal Cancer, Colorectal Carcinoma Trial in Tampa (Pembrolizumab, Ibrutinib)

Completed
  • Colon Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 1, 2022

Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in La Jolla (Venetoclax, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 6, 2021

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Ibrutinib
  • Boston, Massachusetts
  • +1 more
Dec 15, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 22, 2022

Chronic Lymphocytic Leukemia Trial in Cologne (Ibrutinib, Placebo)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib
  • Placebo
  • Cologne, Germany
    German CLL Study Group
Dec 16, 2021

Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • Ibrutinib
  • Laboratory Biomarker Analysis
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 24, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Daratumumab
  • Ibrutinib
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma Trial in Washington, Hackensack, Seattle (Ibrutinib, Venetoclax)

Recruiting
  • Refractory Follicular Lymphoma
  • Relapsed Follicular Lymphoma
  • Washington, District of Columbia
  • +2 more
Jul 6, 2022